John F. Neylan

2016

In 2016, John F. Neylan earned a total compensation of $1M as Chief Medical Officer at Keryx Biopharmaceuticals, a 38% decrease compared to previous year.

Compensation breakdown

Bonus$11,100
Non-Equity Incentive Plan$140,080
Option Awards$251,765
Salary$413,061
Stock Awards$180,063
Other$4,592
Total$1,000,681

Neylan received $413.1K in salary, accounting for 41% of the total pay in 2016.

Neylan also received $11.1K in bonus, $140.1K in non-equity incentive plan, $251.8K in option awards, $180.1K in stock awards and $4.6K in other compensation.

Rankings

In 2016, John F. Neylan's compensation ranked 8,259th out of 14,075 executives tracked by ExecPay. In other words, Neylan earned more than 41.3% of executives.

ClassificationRankingPercentile
All
8,259
out of 14,075
41st
Division
Manufacturing
3,162
out of 5,489
42nd
Major group
Chemicals And Allied Products
1,061
out of 1,895
44th
Industry group
Drugs
826
out of 1,538
46th
Industry
Pharmaceutical Preparations
654
out of 1,176
44th
Source: SEC filing on April 26, 2017.

Neylan's colleagues

We found three more compensation records of executives who worked with John F. Neylan at Keryx Biopharmaceuticals in 2016.

2016

Gregory Madison

Keryx Biopharmaceuticals

Chief Executive Officer

2016

Scott Holmes

Keryx Biopharmaceuticals

Chief Financial Officer

2016

Brian Adams

Keryx Biopharmaceuticals

General Counsel

You may also like